Skip to main content
. Author manuscript; available in PMC: 2016 Apr 17.
Published in final edited form as: Lancet Infect Dis. 2015 Dec 23;16(4):473–479. doi: 10.1016/S1473-3099(15)00401-6

Table 2.

Country-level Fixed Effects Regression Models Predicting Tuberculosis Prevalence, Incidence, and Mortality Rates (N=664)

Prevalence Rate (per 100,000) Incidence Rate (per 100,000) Mortality Rate (per 100,000)

β β β
Social protection, excluding health (percent of GDP) −18·33** (p= 0·009) −8·16* (p= 0·043) −5·48** (p= 0·006)
Social protection2 0·56* (p= 0·049) 0·23 (p= 0·156) 0·18* (p= 0·027)
GDP per capita (2014 US$, thousands) −1·75* (p= 0·034) −0·90 (p= 0·058) −0·17 (p= 0·469)
Adult HIV rate (per 1,000 adults) 5·54*** (p= 0·000) 7·22*** (p= 0·000) 3·47*** (p= 0·000)
Health expenditure(percent of GDP) −2·51 (p= 0·593) −1·87 (p= 0·488) −1·15 (p= 0·384)
Population density (persons per sq. km.) −0·016 (p= 0·831) −0·001 (p= 0·981) 0·007 (p= 0·731)
Foreign-born (percent of population) 12·27 (p= 0·074) 5·55 (p= 0·159) 0·51 (p= 0·789)
TB treatment success rate (percent of new cases) −0·70 (p= 0·131) −0·15 (p= 0·584) −0·28* (p= 0·031)

Notes:

*

p<0.05

**

p<0.01

***

p<0.001. Social protection and its squared term are jointly significant at the .05 level in all three models.